Janux Therapeutics Inc (JANX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: JANX Exchange: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-11-15 2023-11-13 B Purchase

Lichter Jay

Non-Executive Director Large shareholder
849,854 +inf%
5.87
4,988,643 USD 		849,854 +inf% 5.87 4,988,643 USD
2023-11-15 2023-11-13 B Purchase

Reardon Tighe

Acting Chief Financial Officer

Officer Large shareholder
849,854 +inf%
5.87
4,988,643 USD 		849,854 +inf% 5.87 4,988,643 USD
2023-11-13 2023-11-13 B Purchase

Avalon Ventures XI, L.P.

Large shareholder
849,854 +inf%
5.87
4,988,643 USD 		849,854 +inf% 5.87 4,988,643 USD
2023-07-21 2023-07-19 B Purchase

RA CAPITAL MANAGEMENT, L.P.

Non-Executive Director Large shareholder
495,008 +6.5%
12.46
6,167,800 USD 		495,008 +6.5% 12.46 6,167,800 USD
2021-12-23 2021-12-21 S Sale

Thompson Peter A.

Non-Executive Director
11,100 -4.5%
19.00
210,900 USD 		11,100 -4.5% 19.00 210,900 USD
2021-12-23 2021-12-21 S Sale

Thompson Peter A.

Non-Executive Director
108,300 -4.5%
19.00
2,057,700 USD 		108,300 -4.5% 19.00 2,057,700 USD
2021-12-23 2021-12-21 S Sale

ORBIMED ADVISORS LLC

Non-Executive Director
11,100 -4.5%
19.00
210,900 USD 		11,100 -4.5% 19.00 210,900 USD
2021-12-23 2021-12-21 S Sale

ORBIMED ADVISORS LLC

Non-Executive Director
108,300 -4.5%
19.00
2,057,700 USD 		108,300 -4.5% 19.00 2,057,700 USD
2021-12-17 2021-12-16 S Sale

Thompson Peter A.

Non-Executive Director
36,500 -12.9%
19.07
696,055 USD 		36,500 -12.9% 19.07 696,055 USD
2021-12-17 2021-12-16 S Sale

Thompson Peter A.

Non-Executive Director
356,800 -12.9%
19.07
6,804,176 USD 		356,800 -12.9% 19.07 6,804,176 USD
2021-12-17 2021-12-16 S Sale

ORBIMED ADVISORS LLC

Non-Executive Director
36,500 -12.9%
19.07
696,055 USD 		36,500 -12.9% 19.07 696,055 USD
2021-12-17 2021-12-16 S Sale

ORBIMED ADVISORS LLC

Non-Executive Director
356,800 -12.9%
19.07
6,804,176 USD 		356,800 -12.9% 19.07 6,804,176 USD
2021-06-16 2021-06-15 B Purchase

RA CAPITAL MANAGEMENT, L.P.

Non-Executive Director Large shareholder
188,986 +22.0%
17.00
3,212,762 USD 		188,986 +22.0% 17.00 3,212,762 USD
2021-06-16 2021-06-15 B Purchase

RA CAPITAL MANAGEMENT, L.P.

Non-Executive Director Large shareholder
2,752,190 +56.5%
17.00
46,787,230 USD 		2,752,190 +56.5% 17.00 46,787,230 USD
2021-06-16 2021-06-15 B Purchase

ORBIMED ADVISORS LLC

Non-Executive Director
117,650 +71.4%
17.00
2,000,050 USD 		117,650 +71.4% 17.00 2,000,050 USD
2021-06-16 2021-06-15 B Purchase

ORBIMED ADVISORS LLC

Non-Executive Director
588,203 +27.1%
17.00
9,999,451 USD 		588,203 +27.1% 17.00 9,999,451 USD
2021-06-16 2021-06-15 B Purchase

Thompson Peter A.

Non-Executive Director
117,650 +71.4%
17.00
2,000,050 USD 		117,650 +71.4% 17.00 2,000,050 USD
2021-06-16 2021-06-15 B Purchase

Thompson Peter A.

Non-Executive Director
588,203 +27.1%
17.00
9,999,451 USD 		588,203 +27.1% 17.00 9,999,451 USD
2021-06-16 2021-06-15 B Purchase

Avalon Ventures XI, L.P.

Large shareholder
629,411 +16.3%
17.00
10,699,987 USD 		629,411 +16.3% 17.00 10,699,987 USD
2021-06-16 2021-06-15 B Purchase

Reardon Tighe

Acting Chief Financial Officer

Officer Large shareholder
629,411 +16.3%
17.00
10,699,987 USD 		629,411 +16.3% 17.00 10,699,987 USD
2021-06-16 2021-06-15 B Purchase

Bregua Corp

Large shareholder
58,823 +1.6%
17.00
999,991 USD 		58,823 +1.6% 17.00 999,991 USD